Identification of a human natural killer cell target cell antigen with monoclonal antibodies

D. T. Harris, L. Jaso-Friedmann, R. B. Devlin, H. S. Koren, D. L. Evans

Research output: Contribution to journalArticlepeer-review

33 Scopus citations


mAb have been derived against NK cell-sensitive target cells in an effort to identify the target cell structure involved in Ag recognition by NK cells. Several mAb were selected for further study based on their preliminary target cell binding characteristics. Flow cytometry demonstrated that each of these mAb bound to a series of NK-sensitive target cells of various origins (e.g., K562 and Molt-4) while having little or no reactivity with several NK-resistant target cell lines (e.g, SB and Daudi). Functional studies revealed that two of the mAb were able to inhibit the lysis of NK-sensitive K562 target cells by freshly isolated, endogenous NK cells in a dose-dependent fashion. Further, these mAb also could inhibit the killing of K562 target cells by both activated NK cells and cultured lymphokine-activated killer cells, as well as the cytolysis of other NK-sensitive target cells by each of these effector cell populations. Control experiments with another mAb which bound to the target cells but did not inhibit lysis implied that the effects of these mAb on NK cell function was not the result of steric hindrance. Single cell conjugate assays demonstrated that the mAb inhibited NK cell lysis via the inhibition of binding (recognition). Biochemical analysis of this target cell structure revealed that it was a molecule of approximately 42 kDa which may exist as a homodimer in its native state. Thus, it appears that the mAbs identify a unique Ag on the surface of NK cell-sensitive target cells which is involved in NK cell Ag recognition.

Original languageEnglish (US)
Pages (from-to)727-735
Number of pages9
JournalJournal of Immunology
Issue number2
StatePublished - 1989

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology


Dive into the research topics of 'Identification of a human natural killer cell target cell antigen with monoclonal antibodies'. Together they form a unique fingerprint.

Cite this